StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Palisade Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Palisade Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$18.19M. For fiscal 2025 it was -$10.85M. The highest annual figure on record is -$4.77M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.85M–
FY2024Dec 31, 2024-$12.19M–
FY2023Dec 31, 2023-$11.13M–
FY2022Dec 31, 2022-$13.36M–
FY2021Dec 31, 2021-$14.77M–
FY2020Dec 31, 2020-$4.77M–
FY2019Dec 31, 2019-$7.26M–
FY2018Dec 31, 2018-$7.69M–
FY2017Dec 31, 2017-$13.42M–
FY2016Dec 31, 2016-$15.62M–
FY2015Dec 31, 2015-$18.93M–
FY2014Dec 31, 2014-$11.71M–
FY2013Dec 31, 2013-$10.59M–
FY2012Dec 31, 2012-$8.48M–
FY2011Dec 31, 2011-$8.10M–
FY2010Dec 31, 2010-$9.98M–
FY2009Dec 31, 2009-$5.14M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.60M–
Q1 FY2026Mar 31, 2026-$3.89M–
Q4 FY2025Dec 31, 2025-$3.14M–
Q3 FY2025Sep 30, 2025-$3.55M–
Q2 FY2025Jun 30, 2025-$1.82M–
Q1 FY2025Mar 31, 2025-$2.33M–
Q4 FY2024Dec 31, 2024-$2.38M–
Q3 FY2024Sep 30, 2024-$3.13M–
Q2 FY2024Jun 30, 2024-$3.50M–
Q1 FY2024Mar 31, 2024-$3.18M–
Q4 FY2023Dec 31, 2023-$2.75M–
Q3 FY2023Sep 30, 2023-$2.66M–
Q2 FY2023Jun 30, 2023-$2.20M–
Q1 FY2023Mar 31, 2023-$3.53M–
Q4 FY2022Dec 31, 2022-$3.31M–
Q3 FY2022Sep 30, 2022-$3.04M–
Q2 FY2022Jun 30, 2022-$3.25M–
Q1 FY2022Mar 31, 2022-$3.76M–
Q4 FY2021Dec 31, 2021-$3.06M–
Q3 FY2021Sep 30, 2021-$2.75M–
Q2 FY2021Jun 30, 2021-$7.72M–
Q1 FY2021Mar 31, 2021-$1.25M–
Q4 FY2020Dec 31, 2020-$1.55M–
Q3 FY2020Sep 30, 2020-$869.00K–
Q2 FY2020Jun 30, 2020-$673.37K–
Q1 FY2020Mar 31, 2020-$1.68M–
Q4 FY2019Dec 31, 2019-$2.05M–
Q3 FY2019Sep 30, 2019-$1.90M–
Q2 FY2019Jun 30, 2019-$1.64M–
Q1 FY2019Mar 31, 2019-$1.67M–
Q4 FY2018Dec 31, 2018-$1.66M–
Q3 FY2018Sep 30, 2018-$1.66M–
Q2 FY2018Jun 30, 2018-$2.52M–
Q1 FY2018Mar 31, 2018-$1.85M–
Q4 FY2017Dec 31, 2017-$2.29M–
Q3 FY2017Sep 30, 2017-$3.32M–
Q2 FY2017Jun 30, 2017-$3.37M–
Q1 FY2017Mar 31, 2017-$4.44M–
Q4 FY2016Dec 31, 2016-$4.08M–
Q3 FY2016Sep 30, 2016-$4.48M–

More Palisade Bio figures

See a number that looks wrong?